Physician

Ross Zeltser, MD

According to 2025 Medicare claims, Ross Zeltser, MD (NPI: 1194769851) practices micrographic dermatologic surgery in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. This provider's primary affiliated billing organization is HUDSON DERMATOLOGY, PC (NPI: 1508895384; TIN: 200426527) and primary practice location at 12524-1791.

Zeltser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,359 traditional Medicare patients, billed 6,891 HCPCS/CPT codes, and received $1,513,914 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 2,080 prescription claims across 1,491 beneficiaries totaling $256,278 in drug costs, led by Fluorouracil (Fluorouracil). 2019 DME data shows 13 claims. Open Payments data shows 27 records totaling $715. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $36,077 to $256,278. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	967	3,429	$1,000,259
2016	1,205	4,355	$1,207,296
2017	1,113	4,850	$1,022,073
2018	1,188	4,606	$1,058,293
2019	1,240	11,248	$1,112,143
2020	885	6,298	$714,143
2021	1,139	6,773	$1,049,593
2022	1,230	7,120	$1,207,824
2023	1,188	5,803	$1,201,546
2024	1,359	6,891	$1,513,914

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	244	322	$36,077
2016	396	538	$24,262
2017	543	767	$20,949
2018	646	869	$22,452
2019	849	1,295	$56,524
2020	667	990	$28,599
2021	877	1,500	$93,697
2022	1,246	1,878	$86,052
2023	1,268	1,750	$75,890
2024	1,491	2,080	$256,278

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	17	22	$1,969
2018	25	27	$2,622
2019	13	13	$1,340
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	1,104	1,273	$581
17313	Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks	136	154	$527
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	539	645	$361
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	227	227	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	247	340	$73

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	224	6,203	$13,139
Doxycycline Hyclate	Doxycycline Hyclate	1,433	7,026	$4,397
Gentamicin Sulfate	Gentamicin Sulfate	93	2,077	$3,160
Imiquimod	Imiquimod	43	1,299	$1,502
Clobetasol Propionate	Clobetasol Propionate	20	564	$814

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$715	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ross Zeltser, MD?

Tedicare shows public-source Medicare data for Ross Zeltser, MD (NPI 1194769851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ross Zeltser, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ross Zeltser, MD?

Ross Zeltser, MD is linked to HUDSON DERMATOLOGY, PC (billing NPI 1508895384) in the available physician profile data.

Does Ross Zeltser, MD have Open Payments data?

Ross Zeltser, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.